BSX Should Pullback Soon Providing A Buying Opportunity
Boston Scientific Corporation (BSX) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments. It offers devices to diagnose & treat different medical conditions and offer remote patient management systems. It is based in Marlborough, US, comes under Healthcare sector & trades as “BSX” ticker at NYSE.
BSX resumes higher in ((3)) of III showing from previous article from 1.29.2024. It favors upside in ((3)) & should finish between $68.86 - $81.53 area before correcting in ((4)).
BSX - Elliott Wave Latest Daily View:
In weekly sequence, it placed (II) at $24.10 low in March-2020 & II of (III) at $34.98 low in June-2022. Above there, it favors upside in ((3)) of III in bullish impulse sequence between extreme areas. Within III, it placed ((1)) at $55.38 high & pullback of ((2)) at $48.35 low in October-2023 low. It placed (1) of ((1)) at $43.52 high, (2) at $37.74 low, (3) as extended wave at $54.74 high, (4) at $49.69 low & finally (5) as ((1)) at $55.38 high. ((2)) pullback was 0.382 Fibonacci retracement of ((1)).
BSX - Elliott Wave Latest Weekly View:
Above ((2)) low, it placed (1) at $56.90 high, (2) at $54.95 low, (3) at $69.20 high & (4) at $66.80 low as shallow correction. Currently, it favors upside in 3 of (5) & expects two more highs to finish (5) as ((3)) between $68.86 - $81.53 area before any larger correction of ((4)) may starts. We do not recommend selling it in any pullback shown on the chart as it is in bullish sequence. We like to buy the next pullback in ((4)) in 3, 7 or 11 swings at extreme areas.
Source: https://elliottwave-forecast.com/stock-market/bsx-providing-buying-opportunity/
On the date of publication, Elliott Wave Forecast did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.